StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) operating KPIs

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)

Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%

Gilead Sciences scope 1 + Scope 2 (market-based) greenhouse gas emissions (mt CO2e)

Gilead Environmental Sustainability Data Tables (2019–2025)

Latest, FY2025
50,391
Period ended Dec 31, 2025
Change on a year earlier
-29.0%
70,997 in FY2024
History
7 years
Since FY2019
Sources
2
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Breakdown

What makes up scope 1 + scope 2 (market-based) greenhouse gas emissions (mt co2e)

Cite this data

StockData. (2026). Gilead Sciences Scope 1 + Scope 2 (market-based) greenhouse gas emissions (mt CO2e), annual FY2019–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/esg_ghg_scope12_mkt

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.